To hear about similar clinical trials, please enter your email below
Trial Title:
Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening
NCT ID:
NCT05520840
Condition:
Colorectal Cancer
Conditions: Official terms:
Colorectal Neoplasms
Conditions: Keywords:
biomarkers
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
blood sampling for screening of biomarkers
Description:
Patient aged 50 years or older referred for screening colonoscopy after a positive fecal
immunochemical test or for endoscopic resection of a previously identified suspicious
colorectal lesion will have a blood sampling for biomarkers detection
Arm group label:
Patient referred for screening colonoscopy or for endoscopic resection
Summary:
The aim of the study is to validate the value of value of peripheral blood protein
biomarkers in colorectal cancer screening, and to identify new ones
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patient aged 50 years or older referred for screening colonoscopy after a positive
FIT test or for endoscopic resection of a previously identified suspicious
colorectal lesion
Exclusion Criteria:
- Very high risk of colorectal cancer: Lynch syndrome, Familial adenomatous polyposis,
Peutz-Jeghers syndrome, Familial polyposis associated with a MutYH gene defect
- Other solid cancers or haematological malignancies that are progressive and/or
undergoing treatment (apart from basal cell skin carcinoma)
- Contraindication to total colonoscopy
Gender:
All
Minimum age:
50 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Clinique du Cèdre
Address:
City:
Bois-Guillaume
Country:
France
Contact:
Last name:
Aude DI FIORE
Facility:
Name:
Caen University Hospital
Address:
City:
Caen
Country:
France
Contact:
Last name:
Karine BOUHIER, MD
Facility:
Name:
Dijon University Hospital
Address:
City:
Dijon
Country:
France
Contact:
Last name:
Sylvain MANFREDI, Pr
Start date:
September 2022
Completion date:
September 2023
Lead sponsor:
Agency:
University Hospital, Rouen
Agency class:
Other
Collaborator:
Agency:
OncoDiag
Agency class:
Other
Collaborator:
Agency:
University Hospital, Caen
Agency class:
Other
Source:
University Hospital, Rouen
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05520840